Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel in Relapsing Germ Cell Cancer
NCT00002903Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1995
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of docetaxel in germ cell tumor (GCT), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 1995; status: completed.
02
Drugs
docetaxel
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00002903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002903.